Remote monitoring of IBD

• Conditions: Inflammatory bowel disease; Crohn's disease; ulcerative colitis

• Registration Number: NL-OMON21966
• Lead Sponsor: M

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 286

Inclusion Criteria

Established diagnosis of CD or UC according to ECCO guidelines
- Scheduled for an ileocolonoscopy at the endoscopy ward of the MUMC+ (regardless of indication)
- Aged 18 years or older
- Smartphone with internet access (for use of QOC home test)

Exclusion Criteria

- Unclassified IBD
- Ileostomy, colostomy, ileoanal pouch anastomosis or ileorectal anastomosis
- Insufficient knowledge of Dutch language

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The main study endpoint is the diagnostic test accuracy of the below listed remote monitoring tools, using ileocolonoscopy as reference:<br>- MIAH questionnaire with QOC test<br>- Mobile health Index with QOC test<br>- Manitoba IBD index with QOC test<br>- IBD-control with QOC test<br>- QOC test (without questionnaire)

Secondary Outcome Measures

Name	Time	Method
- Agreement between fecal calprotectin levels measured by QOC tests and by routine MUMC+ laboratory tests<br>- Association between the questions used in the various patient based disease activity scores and endoscopic disease activity